Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Euroapi S.A. operates in the pharmaceutical industry, specializing in the development, production, and marketing of active pharmaceutical ingredients (APIs). The company provides an extensive range of complex chemical molecules, including pain management and anesthetics, anti-infectives, and endocrine therapy solutions. Headquartered in Paris, France, Euroapi serves global markets, emphasizing high standards in quality and compliance. The company leverages long-standing expertise and technical capabilities, distinguishing itself with a broad product portfolio and investment in research and development to support innovation and meet diverse customer needs.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Euroapi S.A.Eli Lilly
Last price
€0.78$1,434.17
Currency
EUR
USD
€74M$1.3T
-46.65
-€3.43$30.81
0.960.39
0$6.69
00.48%
Sector
HealthHealth
Employees
2,96150,000
Ticker
€EAPI$LLY
Primary listing
PARNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €EAPI or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.